Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: Does it improve survival?

Hepato-Gastroenterology

Volumn 44, Issue 14, 1997, Pages 567-573

  Takada, Tadahiro ^a   Yasuda, Hideki ^a   Amano, Hodaka ^a   Yoshida, Masahiro ^a   Uchida, Toyohiko ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Liver metastasis; Liver resection; Occult liver metastasis; Pancreatic cancer; Pancreatoduodenectomy

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; CAUSE OF DEATH; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030985533     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ohashi O, Yamamoto M, Ishida H, et al. The present status of multi modality treatment for adenocarcinoma of the pancreas from the Pancreatic Cancer Registry of the Japan Pancreas Society. Kan Tan Sui (in Japanese) 1994; 28:729-735.
2. Child CG, 3rd, Frey CF. Pancreatoduodenectomy. Surg Clin North Am 1966;46:1201-1213.
3. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastasis: A multi institutional study of patterns of recurrence. Surgery 1986; 100:278-284.
4. Takada T, Yasuda H, Uchiyama Hasegawa H. Pylorus-preserving pancreatoduodenectomy for cancer treatment: Surgical procedure, indications, and analysis of outcomes. J Hep Bil Pancr Surg 1994; 1: 367-371.
5. Takada T. Pylorus-preserving pancreatoduodenectomy: its technique and indications. Hepatogastroenterology 1993; 40: 422-425.
6. Japan Pancreatic Society. Classification of Pancreatic Carcinoma. First English Edition. Tokyo: Kanehara Publishing, 1996.
7. International Union Against Cancer: TNM classification of malignant tumors. 4th end. Berlin. Springer-Verlag. 1987.
8. Lillemore KD, Cameron JL, Yeo CJ. et al.: Pancreatoduodenectomy: does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223: 718-728.
9. Collins VP, Loeffer RK, and Tivey H. Observations on growth rates of human tumors. Am J Roentgenol 1956; 76:988-1000.
10. Havelaar IJ, Sugarbaker PH, Vermess M, et al. Rate of growth of intraabdominal metastasis from colorectal cancer. Cancer 1984; 54:163-171.
11. Amikura K, Kobari M, Matsuno S: The growth rates of liver metastasis in pancreatic cancer: comparison of growth rates between clinical cases and established human pancreatic cancer cell lines. Nippon Geka Gakkai Zasshi 1991; 92:562-566 (with English abstract).
12. Inoue S, Nakao A, Kasai Y, et al. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reasction/restriction fragment length polymorphism analysis. Jpn J Cancer Res. 1985; 86: 626-630.